Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Altria in deal talks with cannabis company Cronos Group

Published 2018-12-03, 08:26 p/m
Updated 2018-12-03, 08:30 p/m
© Reuters.  Altria in deal talks with cannabis company Cronos Group

By Greg Roumeliotis and Harry Brumpton

Dec 3 (Reuters) - Marlboro cigarette maker Altria Group (NYSE:MO) Inc MO.N is in discussions with Canadian cannabis producer Cronos Group Inc CRON.TO about making a possible investment, Cronos said on Monday.

The announcement came after Reuters reported on Monday that Altria was in talks to acquire Cronos, as it seeks to diversify its business beyond traditional smokers.

Canada this year legalized recreational use of marijuana, and is seen as a testing ground for pot companies that expect to expand globally as other countries follow suit.

Cronos said no agreement had been reached with respect to any transaction, adding there could be no assurance such discussions would lead to an investment or other transaction involving the companies.

Altria, the parent company of Philip Morris (NYSE:PM) USA, did not respond to a request for comment.

Cronos shares listed on the Nasdaq ended trading on Monday up 11 percent at $10.17, giving the company a market value of about $1.8 billion. Altria shares closed up 1.64 percent at $55.73 on the New York Stock Exchange on Monday.

A deal would mark one of the largest combinations between mainstream tobacco and the booming but volatile marijuana sector, which has seen interest from a variety of major consumer companies that are monitoring the industry for disruptive threats and faster-growing product possibilities.

In June, London-based tobacco company Imperial Brands Plc IMB.L took an undisclosed stake in closely held Oxford Cannabinoid. Constellation Brands Inc (NYSE:STZ) announced a $3.8 billion investment in Canopy Growth Corp WEED.TO in August, while Coca-Cola (NYSE:KO) Co KO.N said in September it was watching the space for alliances that could potentially help it develop products containing cannabinoid oil. shares have fallen by more than 20 percent over the year, as cigarette smoking continues to decline in the United States. Federal data from earlier this month showed cigarette smoking among U.S. adults reached an estimated 14 percent in 2017, the lowest level ever.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Altria has invested in the e-cigarette sector in recent years through its Nu Mark subsidiary. It is also in talks to take a minority stake of between 20 and 40 percent in e-cigarette maker Juul Labs Inc, sources said last week. tobacco companies such as Altria have been investing in e-cigarettes as U.S. tobacco smoking rates decline.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ BREAKINGVIEWS-Big Weed is better off without Big Tobacco embrace

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.